← All Amgen INC filings

Amgen INC Schedule 13G passive stakes

Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.

NASDAQ
AMGN
Amgen INC
SCHEDULE: Vanguard Group Divests Amgen Stake Amid Internal Realignment
The Vanguard Group reported a 0% beneficial ownership in Amgen Inc. common stock following an internal realignment that disaggregated reporting.
NASDAQ
AMGN
Amgen INC
SCHEDULE: Vanguard Group Maintains 10% Stake in Amgen
The Vanguard Group filed an Amendment No. 10 to its Schedule 13G, reporting continued beneficial ownership of 10% of Amgen Inc.'s common stock.
NASDAQ
AMGN
Amgen INC
SCHEDULE 13G/A: BlackRock Amends Schedule 13G, Disclosing 7.6% Passive Stake in Amgen Inc.
BlackRock, Inc. has filed an Amendment No. 15 to its Schedule 13G, reporting a 7.6% beneficial ownership stake in Amgen Inc.'s common stock as of March 31, 2025.